*Clinical Trial

SDT-201

Sonalasense forges ahead with first patient dosing for devastating childhood brain cancer (the "five-year old" girl is Esther)

A Phase 1/2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG

Phase 1/2 DIPG Clinical Trial Design

SonALAsense for Patients

Meet Esther's Team at

Children's National Hospital

Dr. Roger Packer - Neurologist

Dr. Lindsay Kilburn - Neuro-oncologist

Dr. Hasan Syed - Neuro-surgeon

Photographs from childrensnational.org

August 31, 2022 - Children's National Hospital, DC

Esther and her Team before her first treatment of SonALA and LIFU

Meet the Creator of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2

Dr. Stuart Marcus Creates Sonalasense to Treat Deadly Cancers

Dr. Stuart Marcus, Founder and Chief Medical Officer, SonALAsense.COPYRIGHT © 2022 ES9 PHOTOGRAPHY, LLC

**Focused Ultrasound Foundation Sonodynamic Therapy**

Focused Ultrasound Foundation State of the Field Report 2022

Focused Ultrasound for the Pediatric and Young Adult Population

Focused Ultrasound Foundation DIPG Workshop 2021

Meet the Creator of LIFU Device

The White House

Cancer Moonshot for Kids

The White House Live

Page updated

Google Sites

Report abuse